Naganuma A, Makita F, Sugimoto R, Kikuchi M, Furuta K, et al. An open-label, randomized, controlled trial on the benefit of β-hydroxy-β-methyl butyrate, l-arginine, l-glutamine combination beverages and locomotion training as supportive care for the treatment of unresectable hepatocellular carcinoma using lenvatinib: A pilot study (HELLO study). Clin Nutr ESPEN. 2025;65:357. doi:10.1016/j.clnesp.2024.12.005